Showing results (1-10 of 211) with videos related to
Sort By:
Pageof 22
Lancet (London, England)|November 6, 1976
Activation of complement by the alternative pathway as a factor in the pathogenesis of periodontal diseaseA C Allison, H U SchorlemmerImmunology|November 1, 1976
Effects of activated complement components on enzyme secretion by macrophagesH U Schorlemmer, A C AllisonImmunology|June 1, 1977
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammationH U Schorlemmer, D Bitter-Suermann, A C AllisonAgents and Actions|January 1, 1978
The role of macrophage activation in chronic inflammationA C Allison, J Ferluga, H Prydz, et al.Clinical and Experimental Immunology|March 1, 1978
Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effectsJ Ferluga, H U Schorlemmer, L C Baptista, et al.British Journal of Cancer|December 1, 1976
Cytolytic effects of the complement cleavage product, C3aJ Ferluga, H U Schorlemmer, L C Baptista, et al.Arthritis and Rheumatism|September 1, 1977
Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complementE C Keystone, H U Schorlemmer, C Pope, et al.Clinical and Experimental Immunology|February 1, 1977
Macrophage responses to mouldy hay dust, Micropolyspora faeni and zymosan, activators of complement by the alternative pathwayH U Schorlemmer, J H Edwards, P Davies, et al.British Journal of Experimental Pathology|June 1, 1977
The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammationH U Schorlemmer, P Davies, W Hylton, et al.Clinical and Experimental Immunology|September 1, 1978
Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organismsD Taylor-Robinson, H U Schorlemmer, P M Furr, et al.Pageof 22